China price cuts put pressure on foreign drugmakers
New bidding systems make multinationals compete more directly with local generics
Beijing
STARTING from June 1, most drugs in China will be liberated from government-set price caps. For foreign drugmakers, though, pressure to cut prices is rising.
Since late last year, many provincial governments have introduced new bidding systems to lower the cost of medicines they procure, and they're pushing multinationals to compete more directly with cheap local generics on price.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
Nestle sales growth sputters on US slump, vitamin snags
Hermes Q1 sales jump 17% on strong China demand
Cordlife’s independent auditor to retire after issuing disclaimer of opinion on FY2023 financials
Cutting the cord?: Events leading up to Cordlife’s MOH suspension and arrests of its directors, ex-group CEO
Cordlife customers push for legal action
France's Casino supermarket chain to axe up to 3,200 jobs